| Entry |
|
|---|
| Name |
Pizotyline (USAN);
Pizotifen (INN);
Sandomigran (TN)
|
|---|
| Formula |
C19H21NS
|
|---|
| Exact mass |
295.1395
|
|---|
| Mol weight |
295.4417
|
|---|
| Structure |
     |
|---|
| Activity |
Anabolic;
Antidepressant;
Serotonin inhibitor [specific in migraine]
|
|---|
| Remark |
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02C ANTIMIGRAINE PREPARATIONS
N02CX Other antimigraine preparations
N02CX01 Pizotifen
D05523 Pizotyline (USAN); Pizotifen (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
5-HT1-receptor [HSA:3350 3351 3352 3354 3355] [KO:K04153]
Pizotifen [ATC:N02CX01]
D05523 Pizotyline (USAN); Pizotifen (INN)
5-HT2A-receptor [HSA:3356] [KO:K04157]
Pizotifen [ATC:N02CX01]
D05523 Pizotyline (USAN); Pizotifen (INN)
5-HT2C-receptor [HSA:3358] [KO:K04157]
Pizotifen [ATC:N02CX01]
D05523 Pizotyline (USAN); Pizotifen (INN)
 |
|---|
| Other DBs |
CAS: 15574-96-6 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 21
1 C1x C 43.7952 -19.7173
2 C8y C 42.9508 -18.6047
3 C8y C 43.2869 -17.2442
4 C2y C 44.5514 -16.6645
5 C1x C 45.2048 -19.7426
6 C8y C 45.8083 -17.2885
7 C8y C 46.0956 -18.6610
8 C8x C 42.2770 -16.2731
9 C8x C 40.9314 -16.6623
10 C8x C 40.5953 -18.0228
11 C8x C 41.6051 -18.9936
12 S2x S 47.4898 -18.6718
13 C8x C 48.0641 -17.5326
14 C8x C 47.0249 -16.5911
15 C2y C 44.5514 -15.2645
16 C1x C 45.7419 -14.5767
17 C1x C 45.7416 -13.1767
18 N1y N 44.5290 -12.4770
19 C1x C 43.3385 -13.1648
20 C1x C 43.3388 -14.5648
21 C1a C 44.5287 -11.0600
BOND 24
1 3 4 1
2 1 5 1
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 2
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 7 12 1
14 12 13 1
15 13 14 2
16 6 14 1
17 4 15 2
18 15 16 1
19 16 17 1
20 17 18 1
21 18 19 1
22 19 20 1
23 15 20 1
24 18 21 1
|
|---|
